These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 31346598

  • 1. RE-CIRCUIT: uninterrupted anticoagulation with dabigatran to cover left atrial ablation procedures.
    Camm AJ.
    Cardiovasc Res; 2018 Oct 01; 114(12):e89-e90. PubMed ID: 31346598
    [No Abstract] [Full Text] [Related]

  • 2. Real Data on Effectiveness, Tolerability and Safety of New Oral Anticoagulant Agents: Focus on Dabigatran.
    Stabile E, Izzo R, Rozza F, Losi MA, Coscioni E, Trimarco B.
    High Blood Press Cardiovasc Prev; 2016 Jun 01; 23(2):115-22. PubMed ID: 27207360
    [Abstract] [Full Text] [Related]

  • 3. Dabigatran in nonvalvular atrial fibrillation: from clinical trials to real-life experience.
    Mumoli N, Mastroiacovo D, Tamborini-Permunian E, Vitale J, Giorgi-Pierfranceschi M, Cei M, Dentali F.
    J Cardiovasc Med (Hagerstown); 2017 Jul 01; 18(7):467-477. PubMed ID: 28509761
    [Abstract] [Full Text] [Related]

  • 4. Individual Treatment Effect Estimation of 2 Doses of Dabigatran on Stroke and Major Bleeding in Atrial Fibrillation.
    Stam-Slob MC, Connolly SJ, van der Graaf Y, van der Leeuw J, Dorresteijn JAN, Eikelboom JW, Peters RJG, Alings M, Visseren FLJ.
    Circulation; 2019 Jun 18; 139(25):2846-2856. PubMed ID: 31046423
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry.
    Beyer-Westendorf J, Ebertz F, Förster K, Gelbricht V, Michalski F, Köhler C, Werth S, Endig H, Pannach S, Tittl L, Sahin K, Daschkow K, Weiss N.
    Thromb Haemost; 2015 Jun 18; 113(6):1247-57. PubMed ID: 25739533
    [Abstract] [Full Text] [Related]

  • 6. Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation.
    Rillig A, Lin T, Plesman J, Heeger CH, Lemes C, Metzner A, Mathew S, Wissner E, Wohlmuth P, Ouyang F, Kuck KH, Tilz RR.
    J Cardiovasc Electrophysiol; 2016 Feb 18; 27(2):147-53. PubMed ID: 26464027
    [Abstract] [Full Text] [Related]

  • 7. [Dabigatran specific antidote: new safety level in oral anticoagulation].
    MMW Fortschr Med; 2015 Nov 05; 157(19):78-9. PubMed ID: 26953416
    [No Abstract] [Full Text] [Related]

  • 8. Does dabigatran interfere with intraablation heparinization?
    Sairaku A, Nakano Y, Kihara Y.
    Thromb Res; 2014 Sep 05; 134(3):742-3. PubMed ID: 25034323
    [No Abstract] [Full Text] [Related]

  • 9. Stroke and thromboembolism prevention in atrial fibrillation.
    Jame S, Barnes G.
    Heart; 2020 Jan 05; 106(1):10-17. PubMed ID: 31533990
    [Abstract] [Full Text] [Related]

  • 10. Uninterrupted direct oral anticoagulants vs. uninterrupted vitamin K antagonists during catheter ablation of non-valvular atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials.
    Romero J, Cerrud-Rodriguez RC, Diaz JC, Michaud GF, Taveras J, Alviz I, Grupposo V, Cerna L, Avendano R, Kumar S, Kirchhof P, Natale A, Di Biase L.
    Europace; 2018 Oct 01; 20(10):1612-1620. PubMed ID: 29982383
    [Abstract] [Full Text] [Related]

  • 11. Safety of low-dose dabigatran in patients with atrial fibrillation and mild renal insufficiency.
    Fukaya H, Niwano S, Oikawa J, Nishinarita R, Horiguchi A, Nakamura H, Fujiishi T, Igarashi T, Ishizue N, Yoshizawa T, Satoh A, Kishihara J, Murakami M, Ako J.
    J Cardiol; 2017 Mar 01; 69(3):591-595. PubMed ID: 27377855
    [Abstract] [Full Text] [Related]

  • 12. Patient perception of anticoagulant treatment for stroke prevention (RE-SONANCE study).
    Vinereanu D, Napalkov D, Bergler-Klein J, Benczur B, Ciernik M, Gotcheva N, Medvedchikov A, Põder P, Simic D, Skride A, Tang W, Trusz-Gluza M, Vesely J, Vishnepolsky T, Vrabec M.
    Open Heart; 2020 Mar 01; 7(1):e001202. PubMed ID: 32257246
    [Abstract] [Full Text] [Related]

  • 13. Feasibility of Uninterrupted Direct Oral Anticoagulants with Temporary Switching to Dabigatran ("Dabigatran Bridge") for Catheter Ablation of Atrial Fibrillation.
    Aoyama D, Miyazaki S, Hasegawa K, Kaseno K, Ishikawa E, Mukai M, Miyahara K, Aiki T, Matsui A, Yamaguchi J, Shiomi Y, Tama N, Ikeda H, Fukuoka Y, Morishita T, Ishida K, Uzui H, Tada H.
    Int Heart J; 2019 Nov 30; 60(6):1315-1320. PubMed ID: 31735780
    [Abstract] [Full Text] [Related]

  • 14. Postinterventional use of dabigatran in patients undergoing ablation therapy using an accelerated loading dose scheme - a single center experience.
    Seizer P, Gramlich M, Frische C, Gawaz M, Schreieck J.
    Thromb Res; 2015 Aug 30; 136(2):486-7. PubMed ID: 26092430
    [No Abstract] [Full Text] [Related]

  • 15. Safety of dabigatran or rivaroxaban for thoracoscopic ablation in patients with atrial fibrillation.
    Im SI, Jeong DS, Park SJ, Park KM, Huh J, Kim JS, On YK.
    Int J Cardiol; 2015 Aug 30; 186():213-5. PubMed ID: 25828118
    [No Abstract] [Full Text] [Related]

  • 16. Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation- the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study.
    Verdecchia P, Reboldi G, Angeli F, Mazzotta G, Lip GYH, Brueckmann M, Kleine E, Wallentin L, Ezekowitz MD, Yusuf S, Connolly SJ, Di Pasquale G.
    Europace; 2018 Feb 01; 20(2):253-262. PubMed ID: 28520924
    [Abstract] [Full Text] [Related]

  • 17. Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentary.
    Waks JW, Zimetbaum PJ.
    Expert Rev Cardiovasc Ther; 2013 Nov 01; 11(11):1461-71. PubMed ID: 24147516
    [Abstract] [Full Text] [Related]

  • 18. Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.
    Calkins H, Willems S, Gerstenfeld EP, Verma A, Schilling R, Hohnloser SH, Okumura K, Serota H, Nordaby M, Guiver K, Biss B, Brouwer MA, Grimaldi M, RE-CIRCUIT Investigators.
    N Engl J Med; 2017 Apr 27; 376(17):1627-1636. PubMed ID: 28317415
    [Abstract] [Full Text] [Related]

  • 19. Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation: a prospective randomized single-centre study on post-ablation thrombo-embolic and haemorrhagic events.
    Nakamura K, Naito S, Sasaki T, Take Y, Minami K, Kitagawa Y, Motoda H, Inoue M, Otsuka Y, Niijima K, Yamashita E, Sugai Y, Kumagai K, Koyama K, Funabashi N, Oshima S.
    Europace; 2019 Feb 01; 21(2):259-267. PubMed ID: 29982562
    [Abstract] [Full Text] [Related]

  • 20. Effects of dabigatran according to age in atrial fibrillation.
    Lauw MN, Eikelboom JW, Coppens M, Wallentin L, Yusuf S, Ezekowitz M, Oldgren J, Nakamya J, Wang J, Connolly SJ.
    Heart; 2017 Jul 01; 103(13):1015-1023. PubMed ID: 28213368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.